Tirzepatide Research Highlights & Key Studies
Summaries of key studies and research findings involving Tirzepatide.
Tirzepatide has been studied in the SURPASS and SURMOUNT clinical trial programs, demonstrating HbA1c reductions of up to 2.58% and body weight reductions of 16.5% to 22.4% over 72 weeks . Preclinical research has explored its effects on cardiorenal outcomes, hepatic steatosis, and obstructive sleep apnea. The peptide's biased agonism profile has made it a reference standard for researchers investigating optimized GLP-1R signaling and multi-receptor metabolic regulation.
More about Tirzepatide
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption or clinical use. Always follow applicable laws and regulations.